Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Pozycja w akcjach #27863
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Cena akcji
$1.00
Ostatnia synchronizacja: 2023-06-01
Kapitalizacja rynkowa
$30.11M
Zmiana (1 dzień)
2.04%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Angion Biomedica Corp. (ANGN)

Kategoria

Historia ceny akcji dla Angion Biomedica Corp. (ANGN)
Najwyższa cena zamknięcia: $1.00 dnia 2023-06-01

Najniższa cena zamknięcia: $20.49 dnia 2021-02-01
Historia cen akcji firmy Angion Biomedica Corp. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 18.73%
2022 -70.78%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$753.28 5.84%
CH